Subscribe to Newsletter
Business & Regulation Quality & Compliance, Ingredients, Formulation

The Whey of Things

Image credit: Photo by Chris Pellicione / CC BY

Responding to regulators’ calls for clearer guidance on the risks of excipients to patient health, the International Pharmaceutical Excipient Council (IPEC) Federation has published a position paper outlining the safety of the lactose-derived excipient whey (1). A natural polymer, whey is used in various oral dosage forms for its drug-binding capabilities – but some regulatory authorities consider ingredients from human or animal sources to have high chemical and biological risks when incorporated into oral preparations.

IPEC argues that the risk profile of pharmaceutical-grade whey is low because it is sourced from lactose manufactured to GMP standards. Historically, the excipient has also proven to be nontoxic with a good safety profile. The council now hopes that this classification will “result in fewer dossier requirements for lactose when applying for marketing authorizations” – making medicines that contain it more readily available.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. IPEC Federation (2021). Available at https://bit.ly/3d3H6nA.
About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Related White Papers
Highly sensitive and robust LC-MS/MS solution for quantitation of nitrosamine impurities in metformin drug products

| Contributed by Thermo Fisher Scientific

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register